89BIO INC's ticker is ETNB and the CUSIP is 282559103. A total of 70 filers reported holding 89BIO INC in Q1 2022. The put-call ratio across all filers is 0.12 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $9,260,201 | -70.3% | 599,754 | -63.6% | 0.00% | -66.7% |
| Q2 2023 | $31,210,954 | +27.1% | 1,647,016 | +2.1% | 0.00% | 0.0% |
| Q1 2023 | $24,563,538 | +1735.8% | 1,612,839 | +1434.4% | 0.00% | – |
| Q4 2022 | $1,338,063 | +74.5% | 105,111 | -20.6% | 0.00% | – |
| Q3 2022 | $767,000 | +142.0% | 132,365 | +34.6% | 0.00% | – |
| Q2 2022 | $317,000 | +20.1% | 98,359 | +39.9% | 0.00% | – |
| Q1 2022 | $264,000 | -48.1% | 70,309 | +80.5% | 0.00% | – |
| Q4 2021 | $509,000 | -87.9% | 38,956 | -81.8% | 0.00% | -100.0% |
| Q3 2021 | $4,200,000 | -2.7% | 214,384 | -7.1% | 0.00% | 0.0% |
| Q2 2021 | $4,317,000 | -46.1% | 230,879 | -31.7% | 0.00% | 0.0% |
| Q1 2021 | $8,003,000 | -24.8% | 337,970 | -22.7% | 0.00% | -50.0% |
| Q4 2020 | $10,649,000 | +17075.8% | 436,969 | +18061.6% | 0.00% | – |
| Q3 2020 | $62,000 | -92.3% | 2,406 | -94.1% | 0.00% | – |
| Q2 2020 | $809,000 | +274.5% | 40,624 | +374.9% | 0.00% | – |
| Q1 2020 | $216,000 | -70.2% | 8,554 | -68.9% | 0.00% | – |
| Q4 2019 | $724,000 | – | 27,542 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Orchard Capital Management, LLC | 551,879 | $7,025,420 | 2.36% |
| RA Capital Management | 8,955,410 | $114,002,369 | 2.31% |
| Cormorant Asset Management, LP | 2,550,000 | $32,462 | 2.17% |
| Deep Track Capital, LP | 3,850,000 | $49,010,500 | 2.06% |
| COMMODORE CAPITAL LP | 758,244 | $9,652 | 1.46% |
| Ikarian Capital, LLC | 454,000 | $5,779,419 | 1.39% |
| DAFNA Capital Management LLC | 324,173 | $4,126,722 | 1.16% |
| Parkman Healthcare Partners LLC | 332,880 | $4,237,562 | 1.13% |
| Boxer Capital, LLC | 1,400,000 | $17,822,000 | 0.94% |
| Orbimed Advisors | 3,658,869 | $46,577,402 | 0.89% |